TRLV
Trulieve Cannabis Corp. Health Care Medicinal Chemicals & Botanical Products Russell 3000
$10.28Close
$2.0BMarket cap
$4.76 – $13.0052-week range
Nov 5, 2026Next report · before the open
Highlights
Strengths
- Leading the market RS 84 · stronger than 84% of stocks over 12 months
- Volume drying up last 10 days 40% under the 50-day average
Cautions
- Trend not confirmed 7 of 8 conditions · under the 50-day
- Distribution down-day volume 1.5× up-day volume over 50 sessions
- Results soon Nov 5, 2026, in 4 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
21%
1wk
down 1.3%
price change
1mo
down 5.7%
price change
12-month return
up 48%
market up 11% ·
its own up 34%
F-score
5 / 9
Mixed
Altman Z
1.10
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
1.7×
price / book
Earnings yield
up 7.7%
EBIT / enterprise value
Cheaper than
85%
of the market · markedly cheap
Revenue growth
0%
year on year
EPS growth
—
latest quarter
Sales growth
down 10%
latest quarter · -7 pts
ROE
down 10%
return on equity
Free cash margin
up 19%
$228.6M FCF
D/E
0.12
long-term debt / equity
Net debt / EBITDA
-0.5×
net cash
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- issued more shares
- gross margin narrowed
- assets working less efficiently
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- short-term liquidity improved
Repair signals
- Long-term debt down 63% ($0.4B → $0.1B)
Trade setup
ATR%
6.4%
$0.65 a day · 2×ATR $8.97
RS
84 / 99
vs the universe
Trend
7 / 8
under the 50-day
Relative volume
0.7×
vs 50-day average
Up/down volume
0.66
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 7 of 8
- Price above the 50-day average: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Revenue shrinking Revenue fell 0.4% over the year, from $1.2B to $1.2B.
Last reported
May 7, 2026
Last shock
Sep 30, 2026-12% in one session4.9× volumeno filing matched-6% since
Financials
- Gross 60%
- Net -10%
- Free cash 19%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $521.5M | $931.9M | $1.2B | $1.1B | $1.2B | $1.2B |
| Gross margin | 74% | 61% | 57% | 52% | 60% | 60% |
| Operating income | $218.3M | $204.1M | $50.2M | -$221.6M | $97.8M | $143.5M |
| Net income | $63.0M | $18.0M | -$246.1M | -$526.8M | -$155.1M | -$116.4M |
| Net margin | 12% | 2% | -20% | -47% | -13% | -10% |
| Earnings per share | $0.53 | $0.12 | -$1.31 | -$2.79 | -$0.82 | -$0.61 |
| Free cash flow | -$298,000 | -$263.0M | -$141.7M | $161.6M | $148.9M | $228.6M |
| Free cash margin | -0% | -28% | -12% | 14% | 13% | 19% |
| Cash | $146.7M | $226.6M | $207.2M | $201.4M | $238.8M | $255.5M |
| Long-term debt | $6.0M | $462.9M | $541.7M | $363.2M | $364.8M | $136.7M |
| Shareholders' equity | $447.9M | $2.1B | $1.9B | $1.4B | $1.2B | $1.1B |
| Shares outstanding | 119.57m | 180.50m | 185.99m | 186.24m | 191.01m | 192.31m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 7, 2026 | Quarterly ↗ | Jun 30, 2026 | 38d |
| May 7, 2026 | Quarterly ↗ | Mar 31, 2026 | 37d |
| Feb 26, 2026 | Annual ↗ | Dec 31, 2025 | 57d |
| Nov 5, 2025 | Quarterly ↗ | Sep 30, 2025 | 36d |
| Aug 6, 2025 | Quarterly ↗ | Jun 30, 2025 | 37d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 27, 2025 | Annual ↗ | Dec 31, 2024 | 58d |
| Nov 5, 2024 | Quarterly ↗ | Sep 30, 2024 | 36d |
| Aug 6, 2024 | Quarterly ↗ | Jun 30, 2024 | 37d |
| May 9, 2024 | Quarterly ↗ | Mar 31, 2024 | 39d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 9, 2023 | Quarterly ↗ | Sep 30, 2023 | 40d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 11, 2026 | Material agreement · Unregistered share sale · Holder rights changed · Charter or bylaws ↗ |
| Aug 7, 2026 | Acquisition or disposal · Regulation FD ↗ |
| Aug 5, 2026 | Shareholder vote ↗ |
| Jul 2, 2026 | Director or officer change ↗ |
| Jun 12, 2026 | Director or officer change ↗ |
| Jun 11, 2026 | Shareholder vote ↗ |
| Jun 9, 2026 | Other events ↗ |
| Jun 4, 2026 | Material agreement · Acquisition or disposal ↗ |
| May 7, 2026 | Results · Regulation FD ↗ |
| Apr 21, 2026 | Director or officer change ↗ |
| Mar 5, 2026 | Director or officer change ↗ |
| Feb 26, 2026 | Results · Regulation FD ↗ |